Micro-RNAs in the Regulation of Immune Response Against SARS CoV-2 and Other Viral Infections

Overview

Journal J Adv Res

Specialties General Medicine
Science

Date 2020 Dec 7

PMID 33282419

Citations 34

Authors

Tareq Abu-Izneid

Noora AlHajri

Abdallah Mohammad Ibrahim

Md Noushad Javed

Khairi Mustafa Salem

Faheem Hyder Pottoo

Mohammad Amjad Kamal

Affiliations

Soon will be listed here.

Abstract

Background: Micro-RNAs (miRNAS) are non-coding, small RNAs that have essential roles in different biological processes through silencing genes, they consist of 18-24 nucleotide length RNA molecules. Recently, miRNAs have been viewed as important modulators of viral infections they can function as suppressors of gene expression by targeting cellular or viral RNAs during infection.

Aim Of Review: We describe the biological roles and effects of miRNAs on SARS-CoV-2 life-cycle and pathogenicity, and we discuss the modulation of the immune system with micro-RNAs which would serve as a new foundation for the treatment of SARS-CoV-2 and other viral infections.

Key Scientific Concepts Of Review: miRNAs are the key players that regulate the expression of the gene in the post-transcriptional phase and have important effects on viral infections, thus are potential targets in the development of novel therapeutics for the treatment of viral infections. Besides, micro-RNAs (miRNAs) modulation of immune-pathogenesis responses to viral infection is one of the most-known indirect effects, which leads to suppressing of the interferon (IFN-α/β) signalling cascade or upregulation of the IFN-α/β production another IFN-stimulated gene (ISGs) that inhibit replication of the virus. These virus-mediated alterations in miRNA levels lead to an environment that might either enhance or inhibit virus replication.

Citing Articles

The relationship between microRNAs and COVID-19 complications.

Kebriaei A, Besharati R, Namdar Ahmad Abad H, Havakhah S, Khosrojerdi M, Azimian A Noncoding RNA Res. 2024; 10:16-24.

PMID: 39296641 PMC: 11406673. DOI: 10.1016/j.ncrna.2024.08.007.

Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.

Engin A, Engin E, Engin A Adv Exp Med Biol. 2024; 1460:919-954.

PMID: 39287877 DOI: 10.1007/978-3-031-63657-8_31.

Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.

Hassan Kalantar Neyestanaki M, Gholizadeh O, Hosseini Tabatabaie F, Akbarzadeh S, Yasamineh S, Afkhami H Virusdisease. 2024; 35(2):342-356.

PMID: 39071880 PMC: 11269557. DOI: 10.1007/s13337-024-00871-0.

The Potential Roles of Host Cell miRNAs in Fine-Tuning Bovine Coronavirus (BCoV) Molecular Pathogenesis, Tissue Tropism, and Immune Regulation.

Shah A, Hemida M Microorganisms. 2024; 12(5).

PMID: 38792727 PMC: 11124416. DOI: 10.3390/microorganisms12050897.

Identification of miR-29a as a novel biomarker for lumpy skin disease virus exposure in cattle.

Kumar R, Kamboj H, Dhanda S, Verma A, Chander Y, Nehra K Virulence. 2024; 15(1):2324711.

PMID: 38527940 PMC: 10965105. DOI: 10.1080/21505594.2024.2324711.

References

Elbahesh H, Cline T, Baranovich T, Govorkova E, Schultz-Cherry S, Russell C . Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses. J Virol. 2014; 88(12):6714-28. PMC: 4054363. DOI: 10.1128/JVI.00530-14. View

Peer D . A daunting task: manipulating leukocyte function with RNAi. Immunol Rev. 2013; 253(1):185-97. DOI: 10.1111/imr.12044. View

Vigorito E, Perks K, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S . microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007; 27(6):847-59. PMC: 4135426. DOI: 10.1016/j.immuni.2007.10.009. View

Yan B, Wang H, Tan Y, Fu W . microRNAs in Cardiovascular Disease: Small Molecules but Big Roles. Curr Top Med Chem. 2019; 19(21):1918-1947. DOI: 10.2174/1568026619666190808160241. View

Murchison E, Hannon G . miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol. 2004; 16(3):223-9. DOI: 10.1016/j.ceb.2004.04.003. View

Eis P, Tam W, Sun L, Chadburn A, Li Z, Gomez M . Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005; 102(10):3627-32. PMC: 552785. DOI: 10.1073/pnas.0500613102. View

Alanagreh L, Alzoughool F, Atoum M . The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens. 2020; 9(5). PMC: 7280997. DOI: 10.3390/pathogens9050331. View

Hanna J, Hossain G, Kocerha J . The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019; 10:478. PMC: 6532434. DOI: 10.3389/fgene.2019.00478. View

Ji Y, Wrzesinski C, Yu Z, Hu J, Gautam S, Hawk N . miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. Proc Natl Acad Sci U S A. 2014; 112(2):476-81. PMC: 4299215. DOI: 10.1073/pnas.1422916112. View

10.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

11.

Kemp V, Laconi A, Cocciolo G, Berends A, Breit T, Verheije M . miRNA repertoire and host immune factor regulation upon avian coronavirus infection in eggs. Arch Virol. 2020; 165(4):835-843. PMC: 7086581. DOI: 10.1007/s00705-020-04527-4. View

12.

Rossato M, Curtale G, Tamassia N, Castellucci M, Mori L, Gasperini S . IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci U S A. 2012; 109(45):E3101-10. PMC: 3494907. DOI: 10.1073/pnas.1209100109. View

13.

Dudda J, Salaun B, Ji Y, Palmer D, Monnot G, Merck E . MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity. 2013; 38(4):742-53. PMC: 3788592. DOI: 10.1016/j.immuni.2012.12.006. View

14.

Konermann S, Brigham M, Trevino A, Joung J, Abudayyeh O, Barcena C . Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2014; 517(7536):583-8. PMC: 4420636. DOI: 10.1038/nature14136. View

15.

Guinea-Viniegra J, Jimenez M, Schonthaler H, Navarro R, Delgado Y, Concha-Garzon M . Targeting miR-21 to treat psoriasis. Sci Transl Med. 2014; 6(225):225re1. DOI: 10.1126/scitranslmed.3008089. View

16.

Thai T, Calado D, Casola S, Ansel K, Xiao C, Xue Y . Regulation of the germinal center response by microRNA-155. Science. 2007; 316(5824):604-8. DOI: 10.1126/science.1141229. View

17.

Tribolet L, Kerr E, Cowled C, Bean A, Stewart C, Dearnley M . MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing. Front Microbiol. 2020; 11:1197. PMC: 7286131. DOI: 10.3389/fmicb.2020.01197. View

18.

Liu C, Zhou Q, Li Y, Garner L, Watkins S, Carter L . Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Cent Sci. 2020; 6(3):315-331. PMC: 10467574. DOI: 10.1021/acscentsci.0c00272. View

19.

Garchow B, Bartulos Encinas O, Leung Y, Tsao P, Eisenberg R, Caricchio R . Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med. 2011; 3(10):605-15. PMC: 3258486. DOI: 10.1002/emmm.201100171. View

20.

Zhang Y, Li Y . MicroRNAs in the regulation of immune response against infections. J Zhejiang Univ Sci B. 2013; 14(1):1-7. PMC: 3542953. DOI: 10.1631/jzus.B1200292. View